Notable Labs Overview
- Founded
-
2014
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$10.1M
- Investors
-
44
Notable Labs General Information
Description
Operator of therapeutics company intended to develop predictive precision medicines. The company uses a platform that combines machine learning, automation, and high-throughput screening directly on patient samples to predict responses to potential therapies, and ultimately determine which therapies will be most effective for specific cancers, helping patients to get the right treatment and enabling pharmaceutical companies to get new therapies to patients faster.
Contact Information
Website
www.notablelabs.com
Formerly Known As
StemCycle
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Biotechnology
Laboratory Services (Healthcare)
Primary Office
- 950 Tower Lane
- Suite 1975
- Foster City, CA 94404
- United States
+1 (415) 000-0000
Notable Labs Timeline
Notable Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 15-Jul-2022 | $10.1M | 000.00 | Completed | Clinical Trials - Phase 2 | |
| 10. Secondary Transaction - Private | 02-Jun-2022 | 000.00 | Completed | Clinical Trials - Phase 2 | ||
| 9. Later Stage VC | 10-Dec-2021 | 000 | 000.00 | Completed | Clinical Trials - Phase 2 | |
| 8. Later Stage VC (Series B2) | 08-Nov-2019 | 0000 | 000.00 | 00000 | Completed | Clinical Trials - Phase 2 |
| 7. Early Stage VC (Series A1) | 16-Aug-2017 | 000.00 | 000.00 | 000.00 | Completed | Clinical Trials - Phase 2 |
| 6. Early Stage VC | 15-Mar-2017 | 00.000 | 00.000 | Completed | Clinical Trials - Phase 2 | |
| 5. Early Stage VC | 16-May-2016 | 00.000 | 00.000 | Completed | Startup | |
| 4. Seed Round | 01-Jun-2015 | 00000 | Completed | Startup | ||
| 3. Accelerator/Incubator | 24-Mar-2015 | $120K | $120K | 00.000 | Completed | Startup |
| 2. Seed Round | 01-Mar-2015 | Completed | Startup |
Notable Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 000 | |
| Series B-1 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A-6 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A-5 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A-4 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A-3 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A-2 | 1,194,403 | $0.001000 | $2.62 | $2.62 | 1x | $2.62 | 4.53% | |
| Series A-1 | 3,583,743 | $0.001000 | $2.92 | $2.92 | 1x | $2.92 | 13.58% |
Notable Labs Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of therapeutics company intended to develop predictive precision medicines. The company uses a platform that co
Drug Discovery
Foster City, CA
40
As of 2022
000.00
0000000000 0
000.00
000000
im veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis a
0000000000 00000000 (0000000000)
San Francisco, CA
000
As of 0000
00000
0.00
0000-00-00
00000000000
00000
000000
strud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
0000 000000000
Cambridge, MA
00
As of 0000
00000
00000000000
00000
Add Comparison
Notable Labs Competitors (10)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Freenome | Venture Capital-Backed | San Francisco, CA | 000 | 00000 | 00000000000 | 00000 |
| 000000 00000000000 | Venture Capital-Backed | Cambridge, MA | 00 | 00000 | 00000000000 | 00000 |
| 00000 00000000 | Venture Capital-Backed | San Francisco, CA | 00 | 00000 | 00000000000 | 00000 |
| 00000000 00000000 | Venture Capital-Backed | Hong Kong, Hong Kong | 00 | 00000 | 00000000000 | 00000 |
| 0000000 00000000 | Formerly Angel backed | San Diego, CA | 00 | 00000 | 000000000 | 00000 |
Notable Labs Patents
Notable Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200046737-A1 | Methods for treating cancer, and compositions therefor | Abandoned | 09-Aug-2018 | 0000000000 |
Notable Labs Executive Team (15)
Notable Labs Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Adam Seabrook | B Capital Group | Board Member | 000 0000 |
| James Kim | Builders VC | Board Member | 000 0000 |
| Matthew De Silva | Notable Labs | Co-Founder & Chairman | 000 0000 |
| Thomas Bock MD | Notable Labs | Chief Executive Officer & Board Member | 000 0000 |
Notable Labs Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Notable Labs Investors (44)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Chuck Ng | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| Daniel Fain | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| Jared Gross | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| Joe Greenstein | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| Nat Turner | Angel (individual) | Minority | 000 0000 | 000000 0 |